Medical Oxygen Concentrators Sales

Medical Oxygen Concentrators Sales Market Outlook

The global Medical Oxygen Concentrators market is anticipated to reach a valuation of approximately USD 4.25 billion by 2035, with a compound annual growth rate (CAGR) of around 10.1% during the forecast period from 2025 to 2035. The growth of this market can be attributed to several factors, including the increasing prevalence of respiratory diseases, particularly due to the aging population and the ongoing impact of environmental pollutants. Furthermore, the rising awareness of home healthcare solutions and technological advancements in oxygen concentrator devices are fostering substantial market growth. The increasing number of hospital admissions related to respiratory ailments is also driving demand for both stationary and portable oxygen concentrators, contributing to a more robust healthcare infrastructure globally. Additionally, the COVID-19 pandemic has notably accelerated the need for medical oxygen, further propelling the adoption of oxygen concentrators across various healthcare settings.

Growth Factor of the Market

One of the primary growth factors for the Medical Oxygen Concentrators market is the rising prevalence of chronic respiratory diseases, such as Chronic Obstructive Pulmonary Disease (COPD), asthma, and other lung-related conditions. As more individuals are diagnosed with these ailments, the demand for supplemental oxygen therapy has surged, leading to increased consumption of oxygen concentrators. Furthermore, the emphasis on home care settings is shifting as healthcare systems look to reduce hospital congestion while ensuring patient comfort and compliance with treatment protocols. This trend has encouraged manufacturers to develop more efficient and user-friendly portable options that allow patients to receive oxygen therapy in the comfort of their homes. Another factor driving market growth is the technological advancements in oxygen concentrators, such as improved efficiency, lower noise levels, and enhanced portability, making these devices more appealing to patients and healthcare providers alike. Lastly, government initiatives aimed at improving healthcare access and affordability are creating a conducive environment for market expansion, particularly in developing regions where healthcare infrastructure is being continuously enhanced.

Key Highlights of the Market

• The global Medical Oxygen Concentrators market is anticipated to grow at a significant pace due to rising respiratory disease prevalence.
• Increased focus on home healthcare solutions is driving demand for portable and stationary oxygen concentrators.
• Technological advancements in oxygen concentrators are enhancing user experience and treatment efficacy.
• The COVID-19 pandemic has underscored the importance of oxygen therapy, leading to increased demand.
• Government initiatives to improve healthcare access are positively influencing market growth, especially in emerging economies.

By Product Type

Stationary Medical Oxygen Concentrators:

Stationary Medical Oxygen Concentrators are designed for use at home or in clinical environments where patients require a continuous supply of oxygen over an extended period. These devices are typically larger and provide a higher output of oxygen compared to portable alternatives. The demand for stationary models is driven by their ability to deliver a consistent flow of oxygen, which is critical for patients with severe respiratory conditions. Features such as built-in humidifiers and advanced filtration systems also enhance their usability. The stationary oxygen concentrators are particularly advantageous for long-term oxygen therapy, especially for patients with conditions like COPD or pulmonary fibrosis, where consistent oxygen levels are a necessity. Innovations in design and technology have also improved the reliability and efficiency of these devices, further solidifying their position in the market.

Portable Medical Oxygen Concentrators:

Portable Medical Oxygen Concentrators are designed for individuals who require oxygen therapy while on the move. These devices are lightweight and compact, allowing for easy transportation and use in various settings, including travel and outdoor activities. The surge in demand for portable concentrators has been influenced by the growing inclination towards maintaining active lifestyles among oxygen-dependent patients. Manufacturers are continuously improving the battery life and output capabilities of portable models, making them increasingly efficient and user-friendly. Furthermore, advancements in technology have led to the integration of smart features, such as mobile app connectivity and real-time monitoring, enhancing the patient experience. The flexibility and convenience offered by portable oxygen concentrators are propelling their adoption among younger patients and those who prefer not to be confined to their homes.

Dual-flow Medical Oxygen Concentrators:

Dual-flow Medical Oxygen Concentrators are specialized devices designed to provide oxygen to two patients simultaneously. These concentrators are particularly useful in clinical settings, such as hospitals and emergency care facilities, where multiple patients may require supplemental oxygen at the same time. The ability to deliver oxygen to two individuals from a single unit not only optimizes space but also reduces overall equipment costs. The rising incidence of respiratory emergencies and the need for efficient resource management during crisis situations are driving the demand for dual-flow concentrators. Additionally, advancements in technology have improved the reliability and safety features of these devices, further enhancing their appeal to healthcare providers. As healthcare systems strive for efficiency and cost-effectiveness, dual-flow oxygen concentrators are becoming increasingly relevant in the market.

Continuous Flow Medical Oxygen Concentrators:

Continuous Flow Medical Oxygen Concentrators are designed to deliver a steady supply of oxygen at a consistent flow rate, which is essential for patients requiring long-term oxygen therapy. These devices are often utilized in home care settings due to their reliability in providing a constant oxygen supply. Continuous flow concentrators are particularly effective for patients with significant respiratory conditions who need uninterrupted oxygen therapy to manage their symptoms effectively. The growing recognition of the importance of continuous oxygen therapy in improving the quality of life for patients with chronic respiratory diseases is propelling the demand for these devices. Innovations in continuous flow technology have led to more energy-efficient models that are quieter and more compact, making them increasingly appealing for home use.

Pulse Dose Medical Oxygen Concentrators:

Pulse Dose Medical Oxygen Concentrators operate on demand, delivering oxygen only when the patient inhales. This feature allows for greater efficiency and conservation of oxygen, making them suitable for patients who do not require a continuous flow. The demand for pulse dose concentrators is rising, especially among active patients who prefer mobility and convenience. The key advantage of these devices is their ability to extend battery life, which is critical for portable use. Manufacturers are focusing on enhancing the precision of the pulse dose delivery system to ensure patients receive the appropriate amount of oxygen with each breath. As awareness of the benefits of pulse dose technology increases, particularly among younger and more mobile patient populations, the market for these concentrators is expected to expand significantly.

By Application

Home Care:

The home care segment is one of the largest applications for medical oxygen concentrators, as patients increasingly opt for receiving treatment in the comfort of their homes. This shift has been largely driven by the growing preference for home healthcare solutions among patients with chronic respiratory diseases, which require long-term oxygen therapy. The convenience, familiarity, and comfort that home care provides can significantly enhance patient adherence to therapy regimens. Additionally, advancements in portable oxygen concentrators have made it easier for patients to manage their conditions independently, further reinforcing the demand for home care solutions. The increasing popularity of telemedicine and home healthcare monitoring systems is also contributing to the growth of this segment, as patients can maintain close communication with healthcare providers while managing their treatment at home. As more healthcare professionals advocate for home-based treatments, the home care application is expected to continue expanding.

Hospitals:

Hospitals represent a critical application area for medical oxygen concentrators, as they require reliable oxygen supply systems to treat patients in emergency and intensive care settings. The rising number of hospital admissions due to respiratory diseases necessitates efficient and effective oxygen delivery systems, making medical oxygen concentrators essential in hospital environments. The availability of stationary concentrators in hospitals allows for constant oxygen supply to patients in need, especially those undergoing surgeries or recovering from respiratory distress. Moreover, the growing focus on patient-centric care in hospitals encourages the adoption of advanced technology, such as portable and dual-flow concentrators, to enhance patient experience and treatment outcomes. As healthcare facilities continue to adapt to the increased demand for critical care and oxygen therapy, the hospital application segment is likely to witness significant growth.

Ambulatory Surgical Centers:

Ambulatory Surgical Centers (ASCs) are increasingly adopting medical oxygen concentrators to provide oxygen therapy to patients undergoing outpatient surgery. The use of oxygen concentrators in ASCs is essential for managing patients postoperatively, especially those with underlying respiratory conditions. These centers benefit from the portability of oxygen concentrators, enabling efficient oxygen delivery in outpatient settings where space is often limited. The rising trend of outpatient surgeries, coupled with the need for immediate postoperative care, is significantly influencing the demand for medical oxygen concentrators in ASCs. As the healthcare landscape evolves toward more cost-effective and patient-friendly care models, the integration of oxygen therapy in ASCs is expected to grow, further driving the market for medical oxygen concentrators.

Emergency Medical Services:

Emergency Medical Services (EMS) play a crucial role in providing immediate medical assistance, and medical oxygen concentrators are vital tools in this context. EMS units require portable oxygen solutions that can be quickly deployed in emergencies, especially during transport to hospitals. The demand for oxygen concentrators in EMS is driven by the need for efficient and reliable oxygen delivery systems that can accommodate a variety of respiratory conditions. These devices enhance the capability of paramedics to administer oxygen therapy in critical situations, improving patient outcomes during transport. As the frequency of medical emergencies increases, particularly in urban environments, the role of oxygen concentrators in EMS will become more prominent, driving further adoption in this segment.

Others:

This segment includes various applications of medical oxygen concentrators beyond the traditional settings of home care, hospitals, and emergency medical services. Other applications may encompass rehabilitation centers, nursing homes, and industrial settings where oxygen is employed for specific therapeutic or operational purposes. The rising recognition of the importance of occupational health and safety, particularly in industries dealing with hazardous materials, is contributing to the growth of medical oxygen concentrators in these non-traditional applications. Furthermore, advancements in technology are expanding the functionality of concentrators, allowing for specialized uses in diverse fields. As industries continuously seek to improve safety and efficiency, the potential applications for medical oxygen concentrators will likely expand, providing additional growth opportunities for the market.

By Distribution Channel

Direct Sales:

Direct sales of medical oxygen concentrators are a significant distribution channel, allowing manufacturers to sell their products directly to healthcare providers and patients. This approach fosters close relationships between manufacturers and clients, facilitating better understanding of customer needs and preferences. Direct sales also enable manufacturers to provide specialized training and support for customers, ensuring proper usage and maintenance of the devices. This channel is particularly beneficial when introducing new products that require detailed demonstrations or explanations. Furthermore, direct sales help manufacturers maintain control over pricing and branding strategies, which can enhance their competitive positioning in the market. As customer preferences evolve, the direct sales channel is likely to remain a crucial component of the distribution strategy for medical oxygen concentrators.

Distributor Sales:

Distributor sales form another critical distribution channel for medical oxygen concentrators, enabling manufacturers to reach a broader customer base through established networks. Distributors typically have extensive knowledge of local markets and customer demographics, allowing for efficient distribution and marketing of oxygen concentrators. This channel is advantageous for manufacturers looking to expand their market presence without the complexities associated with direct sales. Additionally, distributors often provide valuable services, such as after-sales support, maintenance, and repair services, enhancing customer satisfaction and loyalty. As the demand for medical oxygen concentrators grows, distributors will play an essential role in ensuring product availability and accessibility across various regions, thereby contributing to market expansion.

By Technology

Pressure Swing Adsorption Technology:

Pressure Swing Adsorption (PSA) technology is a widely used method in the production of medical oxygen concentrators, enabling the efficient separation of oxygen from ambient air. This technology operates by compressing air and passing it through a series of adsorbent materials that selectively capture nitrogen, allowing for the concentrated oxygen output required by patients. PSA technology is recognized for its reliability and consistent performance, making it a preferred choice in both stationary and portable medical oxygen concentrators. The growing demand for efficient oxygen delivery systems, particularly in home care settings, is driving the adoption of PSA technology. As manufacturers continue to innovate and improve PSA processes, the technology is expected to remain at the forefront of medical oxygen concentrator advancements.

Continuous Flow Technology:

Continuous Flow Technology is another significant method utilized in medical oxygen concentrators, designed to provide a steady and uninterrupted flow of oxygen to patients. This technology is particularly beneficial for individuals requiring long-term oxygen therapy, as it ensures that users receive a consistent supply without interruptions. Continuous flow devices are commonly used in clinical settings, such as hospitals and rehabilitation centers, where patients may require ongoing oxygen support. The demand for continuous flow technology is driven by its effectiveness in managing severe respiratory conditions and its reliability in delivering therapeutic oxygen. As healthcare systems increasingly emphasize patient-centric care, continuous flow technology remains a vital aspect of oxygen therapy solutions.

Pulse Dose Technology:

Pulse Dose Technology represents an innovative approach to oxygen delivery, allowing medical oxygen concentrators to release oxygen only when the patient inhales. This on-demand feature enhances efficiency, reducing oxygen waste and extending the battery life of portable devices. The rising popularity of pulse dose technology can be attributed to its suitability for active patients who require mobility and convenience in their oxygen therapy. Manufacturers are continually refining pulse dose systems to improve accuracy and responsiveness, ensuring that patients receive the appropriate amount of oxygen with each breath. As the market for portable oxygen concentrators expands, pulse dose technology is expected to play a significant role in meeting the needs of various patient demographics.

By Region

The Medical Oxygen Concentrators market is segmented by region, with North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa being the key regions. North America holds a significant share of the market, driven by advanced healthcare infrastructure, a high prevalence of respiratory diseases, and an increasing aging population. In 2025, the North American market is projected to reach approximately USD 1.8 billion, growing at a CAGR of 9.5% through 2035. The regulatory framework in North America is conducive to the development and approval of medical devices, further supporting market growth. Coupled with the growing adoption of home healthcare solutions, North America is expected to maintain its dominance in the Medical Oxygen Concentrators market.

Europe follows closely, showcasing a robust demand for medical oxygen concentrators due to a strong emphasis on healthcare services and a significant population suffering from chronic respiratory diseases. The region is projected to experience steady growth, with an estimated market value of USD 1.2 billion by 2035. The awareness of home-based healthcare solutions is increasing, driving greater adoption of portable and stationary oxygen concentrators. Moreover, the presence of major healthcare players and significant investments in healthcare infrastructure are contributing to the overall growth of the Medical Oxygen Concentrators market in Europe. The Asia Pacific region is also witnessing significant growth, primarily fueled by rising healthcare investments and increasing patient populations. As developing nations continue to improve their healthcare infrastructure, the demand for medical oxygen concentrators is expected to rise accordingly, providing a promising outlook for this segment.

Opportunities

The Medical Oxygen Concentrators market presents opportunities for innovation and expansion, particularly in the development of advanced, user-friendly devices that cater to the needs of patients with varying degrees of respiratory conditions. The increasing trend towards home healthcare is creating a demand for more portable and efficient oxygen concentrators, which manufacturers can capitalize on by investing in research and development. With the growing emphasis on personalized medicine, there is potential for tailored oxygen therapy solutions that can improve patient outcomes and satisfaction. Additionally, as telemedicine and remote patient monitoring continue to gain traction, integrating smart technologies into oxygen concentrators could enhance their functionality and appeal. Collaborations with healthcare providers and technology companies can foster innovation in product designs, leading to more versatile and effective oxygen therapy solutions.

Another significant opportunity lies in expanding reach into emerging markets, where healthcare infrastructure is improving and the prevalence of respiratory diseases is on the rise. Manufacturers can capitalize on this growth by establishing strategic partnerships with local distributors and healthcare providers to enhance product accessibility. Educational outreach and awareness campaigns can also play a pivotal role in informing patients and healthcare professionals about the benefits of oxygen therapy, potentially driving higher adoption rates. As more governments and organizations commit to improving healthcare access, particularly in underserved populations, the Medical Oxygen Concentrators market stands to benefit from increased investment and support.

Threats

Despite the promising growth trajectory of the Medical Oxygen Concentrators market, several threats could hinder its progress. One of the most significant threats is the potential for regulatory challenges and stringent approval processes that can delay the introduction of new products. Manufacturers must navigate a complex landscape of regulations, which can vary significantly from region to region. Compliance with these regulations requires substantial investments in research, development, and quality assurance, which can strain resources for smaller companies. Additionally, the presence of alternative oxygen delivery systems, such as liquid oxygen tanks and compressed oxygen cylinders, can pose competitive threats to the market for oxygen concentrators. As patients weigh their options, manufacturers must not only focus on product innovation but also on differentiating their offerings in a crowded market.

Another concern is the potential for market saturation, particularly in developed regions where the adoption of medical oxygen concentrators has been widespread. As competition intensifies, pricing pressures may arise, forcing manufacturers to lower prices or invest more heavily in marketing and brand positioning to maintain market share. Additionally, fluctuations in raw material costs and supply chain disruptions could impact production timelines and costs, potentially affecting overall profitability. These challenges necessitate strategic planning and adaptability from market players to mitigate risks and ensure sustained growth in a dynamic healthcare environment.

Competitor Outlook

• Philips Respironics
• Invacare Corporation
• Drive DeVilbiss Healthcare
• OxyGo LLC
• AirSep Corporation
• CAIRE Inc.
• Chart Industries
• GCE Healthcare
• Medtronic
• DeVilbiss Healthcare
• Precision Medical
• Inogen Inc.
• Welch Allyn
• ResMed
• Oxygen Concentrator Store

The competitive landscape of the Medical Oxygen Concentrators market is characterized by the presence of several key players, each vying for market share through product innovation, strategic partnerships, and customer-focused solutions. Companies such as Philips Respironics and Invacare Corporation are at the forefront of the market, leveraging their extensive experience in medical devices to develop advanced oxygen therapy solutions that cater to the diverse needs of patients. Their strong distribution networks and commitment to quality have positioned them as trusted brands in the industry. Additionally, organizations like Drive DeVilbiss Healthcare and CAIRE Inc. are innovating rapidly, offering a range of products that emphasize portability and user-friendly designs, catering to the growing demand for home healthcare solutions.

Emerging companies, such as Inogen Inc. and OxyGo LLC, are making significant strides in the market by focusing on portable oxygen concentrators that appeal to younger, more active patient populations. These companies are capitalizing on the trend towards mobility and convenience in oxygen therapy, positioning their products as essential tools for maintaining an active lifestyle. Furthermore, established players like ResMed and Medtronic are leveraging their extensive R&D capabilities to introduce cutting-edge technologies that improve the efficiency and effectiveness of oxygen therapy. This dynamic interplay of competition and innovation is expected to shape the future of the Medical Oxygen Concentrators market, as companies strive to meet evolving patient needs and preferences.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 ResMed
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 OxyGo LLC
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 CAIRE Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Inogen Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Welch Allyn
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 GCE Healthcare
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Chart Industries
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Precision Medical
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 AirSep Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Philips Respironics
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 DeVilbiss Healthcare
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Invacare Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Oxygen Concentrator Store
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Drive DeVilbiss Healthcare
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Medical Oxygen Concentrators Sales Market, By Technology
    • 6.1.1 Pressure Swing Adsorption Technology
    • 6.1.2 Continuous Flow Technology
    • 6.1.3 Pulse Dose Technology
  • 6.2 Medical Oxygen Concentrators Sales Market, By Application
    • 6.2.1 Home Care
    • 6.2.2 Hospitals
    • 6.2.3 Ambulatory Surgical Centers
    • 6.2.4 Emergency Medical Services
    • 6.2.5 Others
  • 6.3 Medical Oxygen Concentrators Sales Market, By Product Type
    • 6.3.1 Stationary Medical Oxygen Concentrators
    • 6.3.2 Portable Medical Oxygen Concentrators
    • 6.3.3 Dual-flow Medical Oxygen Concentrators
    • 6.3.4 Continuous Flow Medical Oxygen Concentrators
    • 6.3.5 Pulse Dose Medical Oxygen Concentrators
  • 6.4 Medical Oxygen Concentrators Sales Market, By Distribution Channel
    • 6.4.1 Direct Sales
    • 6.4.2 Distributor Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Medical Oxygen Concentrators Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Medical Oxygen Concentrators Sales market is categorized based on

By Product Type

• Stationary Medical Oxygen Concentrators
• Portable Medical Oxygen Concentrators
• Dual-flow Medical Oxygen Concentrators
• Continuous Flow Medical Oxygen Concentrators
• Pulse Dose Medical Oxygen Concentrators

By Application

• Home Care
• Hospitals
• Ambulatory Surgical Centers
• Emergency Medical Services
• Others

By Distribution Channel

• Direct Sales
• Distributor Sales

By Technology

• Pressure Swing Adsorption Technology
• Continuous Flow Technology
• Pulse Dose Technology

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Philips Respironics
• Invacare Corporation
• Drive DeVilbiss Healthcare
• OxyGo LLC
• AirSep Corporation
• CAIRE Inc.
• Chart Industries
• GCE Healthcare
• Medtronic
• DeVilbiss Healthcare
• Precision Medical
• Inogen Inc.
• Welch Allyn
• ResMed
• Oxygen Concentrator Store